93
Views
7
CrossRef citations to date
0
Altmetric
Methimazole Mediated Radioprotection

Radioprotection of thyroid cells mediated by methimazole

, , , , &
Pages 811-816 | Received 30 Nov 2009, Accepted 20 Apr 2010, Published online: 07 Jul 2010

References

  • Bonnema SJ, Bennedbaek FN, Veje A, Marving J, Hegedus L. 2006. Continuous methimazole therapy and its effect on the cure rate of hyperthyroidism using radioactive iodine: An evaluation by a randomized trial. Journal of Clinical Endocrinology and Metabolism 91:2946–2951.
  • Braunlich H, Appenroth D, Fleck C. 1997. Protective effects of methimazole against cisplatin-induced nephrotoxicity in rats. Journal of Applied Toxicology 17:41–45.
  • Carlin S, Mairs RJ, Welsh P, Zalutsky MR. 2002. Sodium-iodide symporter (NIS)-mediated accumulation of (211)At]astatide in NIS-transfected human cancer cells. Nuclear Medicine and Biology 29:729–739.
  • Collins AR. 2004. The comet assay for DNA damage and repair: Principles, applications, and limitations. Molecular Biotechnology 26:249–261.
  • Crooks J, Buchanan WW, Wayne EJ, Macdonald E. 1960. Effect of pretreatment with methylthiouracil on results of I-131 therapy. British Medical Journal 1:151–154.
  • DeGroot LJ, Buhler U. 1971. Effect of perchlorate and methimazole on iodine metabolism. Acta Endocrinologica 68:696–706.
  • Dohan O, De la Vieja A, Paroder V, Riedel C, Artani M, Reed M, Ginter CS, Carrasco N. 2003. The sodium/iodide symporter (NIS): Characterization, regulation, and medical significance. Endocrine Reviews 24:48–77.
  • Eggo MC, Bachrach LK, Mak W, Burrow GN. 1986. Disparate uptake of 99mTcO4- and 125I- in thyroid cells in culture. Hormone and Metabolic Research 18:167–172.
  • Einhorn J, Saterborg NE. 1962. Antithyroid drugs in iodine 131 therapy of hyperthyroidism. Acta Radiologica 58:161–167.
  • Ferreira AC, de Carvalho Cardoso L, Rosenthal D, de Carvalho DP. 2003. Thyroid Ca2+/NADPH-dependent H2O2 generation is partially inhibited by propylthiouracil and methimazole. European Journal of Biochemistry 270:2363–2368.
  • Forssberg A. 1950. On the possibility of protecting the living organism against roentgen rays by chemical means. Acta Radiologica 33:296–304.
  • Francesconi A, Del Terra E, Meli A, Ambesi-Impiombato FS. 2001. Standardization of the comet assay technique on FRTL5 cells. Physica Medica 17(Suppl. 1):232–234.
  • Frankenberg-Schwager M. 1989. Review of repair kinetics for DNA damage induced in eukaryotic cells in vitro by ionizing radiation. Radiotherapy and Oncology 14:307–320.
  • Freudenberg R, Andreeff M, Oehme L, Kotzerke J. 2009. [Dosimetry of cell-monolayers in multiwell plates]. Nuklearmedizin 48:120–126.
  • Goddu SM, Howell RW, Bouchet LG, Bolch WE, Rao DV. 1997. MIRD Cellular S Values, Society of Nuclear Medicine.
  • Golstein P, Abramow M, Dumont JE, Beauwens R. 1992. The iodide channel of the thyroid: A plasma membrane vesicle study. American Journal of Physiology 263:C590–C597.
  • Haberkorn U, Altmann A, Jiang S, Morr I, Mahmut M, Eisenhut M. 2001. Iodide uptake in human anaplastic thyroid carcinoma cells after transfer of the human thyroid peroxidase gene. European Journal of Nuclear Medicine 28:633–638.
  • Imamura M, Aoki N, Saito T, Ohno Y, Maruyama Y, Yamaguchi J, Yamamoto T. 1986. Inhibitory effects of antithyroid drugs on oxygen radical formation in human neutrophils. Acta Endocrinologica 112:210–216.
  • Jansson R, Dahlberg PA, Johansson H, Lindstrom B. 1983. Intrathyroidal concentrations of methimazole in patients with Graves' disease. Journal of Clinical Endocrinology and Metabolism 57:129–132.
  • Kariya S, Sawada K, Kobayashi T, Karashima T, Shuin T, Nishioka A, Ogawa Y. 2009. Combination treatment of hydrogen peroxide and X-rays induces apoptosis in human prostate cancer PC-3 cells. International Journal of Radiation Oncology, Biology, Physics 75:449–454.
  • Kim H, Lee TH, Hwang YS, Bang MA, Kim KH, Suh JM, Chung HK, Yu DY, Lee KK, Kwon OY, Ro HK, Shong M. 2001. Methimazole as an antioxidant and immunomodulator in thyroid cells: Mechanisms involving interferon-gamma signaling and H(2)O(2) scavenging. Molecular Pharmacology 60:972–980.
  • Kotzerke J, Fenchel S, Guhlmann A, Stabin M, Rentschler M, Knapp FF Jr, Reske SN. 1998. Pharmacokinetics of 99Tcm-pertechnetate and 188Re-perrhenate after oral administration of perchlorate: Option for subsequent care after the use of liquid 188Re in a balloon catheter. Nuclear Medicine Communications 19:795–801.
  • Limperos G, Mosher WA. 1950. Protection of mice against x-radiation by thiourea. Science 112:86–87.
  • Marchant B, Alexander WD, Robertson JW, Lazarus JH. 1971. Concentration of 35S-propylthiouracil by the thyroid gland and its relationship to anion trapping mechanism. Metabolism: Clinical and Experimental 20:989–999.
  • Mole RH, Philpot JL, Hodges GR. 1950. Reduction in lethal effect of x-radiation by pretreatment with thiourea or sodium ethane dithiophosphonate. Nature 166:515.
  • Moseley H, MacFadyen EE, Ferguson MM, Simpson NB. 1989. Reduction of UV-induced erythema in normal subjects by applying methimazole. Photo-Dermatology 6:32–36.
  • Olive PL, Banath JP. 2006. The comet assay: A method to measure DNA damage in individual cells. Nature Protocols 1:23–29.
  • Petrich T, Helmeke HJ, Meyer GJ, Knapp WH, Potter E. 2002. Establishment of radioactive astatine and iodine uptake in cancer cell lines expressing the human sodium/iodide symporter. European Journal of Nuclear Medicine and Molecular Imaging 29:842–854.
  • Rades D, Wolff C, Nadrowitz R, Breunig C, Schild SE, Baehre M, Meller B. 2009. Radioactive EGFR antibody cetuximab in multimodal cancer treatment: stability and synergistic effects with radiotherapy. International Journal of Radiation Oncology, Biology, Physics 75:1226–1231.
  • Reiners C. 1991. Radioiodine treatment of Basedow's disease: Interference and influence factors, risk estimation. Experimental and Clinical Endocrinology 97:275–285.
  • Rugh R. 1953. Thiouracil modification of effect of radioiodine (I131) on the thyroid. Radiology 61:391–400.
  • Runge R, Wendisch M, Wunderlich G, Freudenberg R, Kotzerke J. 2009. [DNA damage in lymphocytes after irradiation with 211At and 188Re]. Nuklearmedizin 48:221–226.
  • Sabri O, Schulz G, Zimny M, Schreckenberger M, Zimny D, Wagenknecht G, Kaiser HJ, Dohmen BM, Bares R, Bull U. 1998. [Determination of factors affecting the therapeutic outcome of radioiodine therapy in patients with Graves' disease]. Nuklearmedizin 37:83–89.
  • Sabri O, Zimny M, Schreckenberger M, Reinartz P, Ostwald E, Buell U. 1999a. Radioiodine therapy in Graves' disease patients with large diffuse goiters treated with or without carbimazole at the time of radioiodine therapy. Thyroid 9:1181–1188.
  • Sabri O, Zimny M, Schulz G, Schreckenberger M, Reinartz P, Willmes K, Buell U. 1999b. Success rate of radioiodine therapy in Graves' disease: The influence of thyrostatic medication. Journal of Clinical Endocrinology and Metabolism 84:1229–1233.
  • Speit G, Hartmann A. 2006. The comet assay: A sensitive genotoxicity test for the detection of DNA damage and repair. Methods in Molecular Biology 314:275–286.
  • Spitzweg C. 2003. [The sodium-iodide symporter. Pathophysiologic, diagnostic and therapeutic significance]. Internist (Berl) 44:396–402, 404–398, 396–411.
  • Van Sande J, Massart C, Beauwens R, Schoutens A, Costagliola S, Dumont JE, Wolff J. 2003. Anion selectivity by the sodium iodide symporter. Endocrinology 144:247–252.
  • Weetman AP, Holt ME, Campbell AK, Hall R, McGregor AM. 1984. Methimazole and generation of oxygen radicals by monocytes: Potential role in immunosuppression. British Medical Journal (Clinical Research Ed.) 288:518–520.
  • Wendisch M, Drechsel J, Freudenberg R, Runge R, Wunderlich G, Kotzerke J. 2009. Cellular damage in vitro. Nuklearmedizin 48:208–214.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.